Durham, NC, United States of America

Ryan Douglas Michalek

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Disease Diagnosis: The Work of Ryan Douglas Michalek

Introduction

Ryan Douglas Michalek, based in Durham, NC, is an accomplished inventor recognized for his contributions to the fields of biochemistry and health diagnostics. With a focus on small molecule biochemical profiling, his work aims to enhance disease diagnosis and health assessment for individuals.

Latest Patents

Ryan has secured a patent titled "Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment". This innovative method outlines how to analyze abnormal levels of small molecules in samples from individuals. The invention facilitates the diagnosis of diseases and disorders, as well as assesses the risk of developing such conditions. Furthermore, it provides critical diagnostic information including the identification of biochemical pathways linked to the aberrant small molecules, associated diseases or disorders, and recommended follow-up tests.

Career Highlights

Ryan currently serves as an inventor at Metabolon, Inc., a company renowned for its pioneering metabolic profiling technology. His role involves the development of advanced methodologies that aid in health diagnostics, showcasing his commitment to improving patient outcomes through innovative science.

Collaborations

During his career, Ryan has had the opportunity to collaborate with esteemed colleagues such as Michael V. Milburn and John A. Ryals. These partnerships have further enhanced his research capabilities and contributed to the successful development of impactful diagnostics.

Conclusion

Ryan Douglas Michalek’s innovative approach to disease diagnosis through small molecule profiling represents a significant advancement in medical diagnostics. His patent reflects not only his expertise in biochemistry but also his dedication to improving healthcare solutions. As he continues his work at Metabolon, Inc., his contributions are anticipated to make lasting impacts in the field of health assessment and disease prevention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…